BIOPROTECTION SYSTEMS CORP.
DESCRIPTION (provided by applicant): Indigenous population, travelers and troops present in Africa and South America are clearly at risk of exposure to several arenaviruses. Several human pathogenic a ...SBIR Phase I 2010 Department of Health and Human Services
The objective of this study is to demonstrate the efficacy and broad applicability of the human immune-modulating alphaGal Adjuvant Technology for antiviral vaccine development. We will use viral vacc ...SBIR Phase I 2008 Office for Chemical and Biological DefenseDepartment of Defense
We hypothesize that the application of the broad-spectrum immune-stimulatory and -modulatory HyperAcute alphaGal Adjuvant Technology will enhance the potency and effectiveness of VEEV vaccine candidat ...SBIR Phase II 2009 Office for Chemical and Biological DefenseDepartment of Defense
This application addresses the USDA NIFA "Global Food Security and Hunger" primary societal challenge area by developing a countermeasure against a potential agricultural disease threat - Ri ...SBIR Phase I 2011 Department of Agriculture